Recently, increasing evidence indicates that TRMT6 is preferentially expressed in cancerous tissues and plays an oncogenic role in various types of cancer, such as glioma,3 bladder cancer1 and hepatocellular carcinoma (HCC).4, 5. The gene discussed is TRMT6; the disease is central nervous system cancer.